Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Merck
Baxter
McKinsey
Mallinckrodt

Last Updated: February 4, 2023

Details for Patent: 7,547,776


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 7,547,776
Title:Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%
Abstract:The present invention generally relates to a fludarabine-phosphate with a purity of at least 99.5%.
Inventor(s): Tilstam; Ulf (Berlin, DE), Schmitz; Thomas (Berlin, DE), Nickisch; Klaus (Berlin, DE)
Assignee: Bayer Schering Pharma Aktiengesellschaft (Berlin, DE)
Application Number:09/471,040
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 7,547,776

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,547,776

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 56 289Dec 11, 1997

International Family Members for US Patent 7,547,776

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 231880 See Plans and Pricing
Austria 8617 See Plans and Pricing
Australia 2155099 See Plans and Pricing
Australia 739574 See Plans and Pricing
Canada 2313486 See Plans and Pricing
Czech Republic 20002159 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Harvard Business School
Dow
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.